Thanaporn Liangsupree
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thanaporn Liangsupree has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Marja-Liisa Riekkola
Department of Chemistry, P.O. Box 55, FI-00014 University of Helsinki, Finland
5 shared publications - Evgen Multia
Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, Aalto, FI-00076, Finland
4 shared publications Patrik Forssén
Department of Engineering and Chemical Sciences, Karlstad University, Karlstad, Sweden
2 shared publications- Torgny Fornstedt
Department of Engineering and Chemical Sciences, Karlstad University, SE-651 88 Karlstad, Sweden
2 shared publications - Aleš Podgornik
Department of Chemical Engineering and Technical Safety, Faculty for Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia
1 shared publication Daniel Wallinder
Attana AB , Björnäsvägen 21 , SE-114 19 Stockholm , Sweden
1 shared publication
Latest Publications
- Open Access
- 2 December 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1767, 466602
Recent advances in modern extracellular vesicle isolation and separation techniques
- 2 December 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1767, 466602
Open AccessRecent advances in modern extracellular vesicle isolation and separation techniques
- 1 October 2025
- Published by Springer Nature
- p. 81-106
Immunoaffinity Chromatography and Field-Flow Fractionation Methods of EV Isolation
- 1 October 2025
- Published by Springer Nature
- p. 81-106
Immunoaffinity Chromatography and Field-Flow Fractionation Methods of EV Isolation
- Top Cited PapersOpen Access
- 1 January 2021
- Published by Elsevier in Journal of Chromatography A
- Vol. 1636, 461773
Modern isolation and separation techniques for extracellular vesicles
- 1 January 2021
- Published by Elsevier in Journal of Chromatography A
- Vol. 1636, 461773
Top Cited PapersOpen AccessModern isolation and separation techniques for extracellular vesicles
- Open Access
- 2 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Rapid affinity chromatographic isolation method for LDL in human plasma by immobilized chondroitin-6-sulfate and anti-apoB-100 antibody monolithic disks in tandem
Low-density lipoprotein (LDL) is considered the major risk factor for the development of atherosclerotic cardiovascular diseases (ASCVDs). A novel and rapid method for the isolation of LDL from human plasma was developed utilising affinity chromatography with monolithic stationary supports. The isolation method consisted of two polymeric monolithic disk columns, one immobilized with chondroitin-6-sulfate (C6S) and the other with apolipoprotein B-100 monoclonal antibody (anti-apoB-100 mAb). The first disk with C6S was targeted to remove chylomicrons, very-low-density lipoprotein (VLDL) particles, and their remnants including intermediate-density lipoprotein (IDL) particles, thus allowing the remaining major lipoprotein species, i.e. LDL, lipoprotein(a) (Lp(a)), and high-density lipoprotein (HDL) to flow to the anti-apoB-100 disk. The second disk captured LDL particles via the anti-apoB-100 mAb attached on the disk surface in a highly specific manner, permitting the selective LDL isolation. The success of LDL isolation was confirmed by different techniques including quartz crystal microbalance. In addition, the method developed gave comparable results with ultracentrifugation, conventionally used as a standard method. The reliable results achieved together with a short isolation time (less than 30 min) suggest the method to be suitable for clinically relevant LDL functional assays.
- 2 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Open AccessRapid affinity chromatographic isolation method for LDL in human plasma by immobilized chondroitin-6-sulfate and anti-apoB-100 antibody monolithic disks in tandem
Low-density lipoprotein (LDL) is considered the major risk factor for the development of atherosclerotic cardiovascular diseases (ASCVDs). A novel and rapid method for the isolation of LDL from human plasma was developed utilising affinity chromatography with monolithic stationary supports. The isolation method consisted of two polymeric monolithic disk columns, one immobilized with chondroitin-6-sulfate (C6S) and the other with apolipoprotein B-100 monoclonal antibody (anti-apoB-100 mAb). The first disk with C6S was targeted to remove chylomicrons, very-low-density lipoprotein (VLDL) particles, and their remnants including intermediate-density lipoprotein (IDL) particles, thus allowing the remaining major lipoprotein species, i.e. LDL, lipoprotein(a) (Lp(a)), and high-density lipoprotein (HDL) to flow to the anti-apoB-100 disk. The second disk captured LDL particles via the anti-apoB-100 mAb attached on the disk surface in a highly specific manner, permitting the selective LDL isolation. The success of LDL isolation was confirmed by different techniques including quartz crystal microbalance. In addition, the method developed gave comparable results with ultracentrifugation, conventionally used as a standard method. The reliable results achieved together with a short isolation time (less than 30 min) suggest the method to be suitable for clinically relevant LDL functional assays.
- Open Access
- 28 March 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (8) , 5366-5374
Reliable Strategy for Analysis of Complex Biosensor Data
When using biosensors, analyte biomolecules of several different concentrations are percolated over a chip with immobilized ligand molecules that form complexes with analytes. However, in many cases of biological interest, e.g., in antibody interactions, complex formation steady-state is not reached. The data measured are so-called sensorgram, one for each analyte concentration, with total complex concentration vs time. Here we present a new four-step strategy for more reliable processing of this complex kinetic binding data and compare it with the standard global fitting procedure. In our strategy, we first calculate a dissociation graph to reveal if there are any heterogeneous interactions. Thereafter, a new numerical algorithm, AIDA, is used to get the number of different complex formation reactions for each analyte concentration level. This information is then used to estimate the corresponding complex formation rate constants by fitting to the measured sensorgram one by one. Finally, all estimated rate constants are plotted and clustered, where each cluster represents a complex formation. Synthetic and experimental data obtained from three different QCM biosensor experimental systems having fast (close to steady-state), moderate, and slow kinetics (far from steady-state) were evaluated using the four-step strategy and standard global fitting. The new strategy allowed us to more reliably estimate the number of different complex formations, especially for cases of complex and slow dissociation kinetics. Moreover, the new strategy proved to be more robust as it enables one to handle system drift, i.e., data from biosensor chips that deteriorate over time.
- 28 March 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (8) , 5366-5374
Open AccessReliable Strategy for Analysis of Complex Biosensor Data
When using biosensors, analyte biomolecules of several different concentrations are percolated over a chip with immobilized ligand molecules that form complexes with analytes. However, in many cases of biological interest, e.g., in antibody interactions, complex formation steady-state is not reached. The data measured are so-called sensorgram, one for each analyte concentration, with total complex concentration vs time. Here we present a new four-step strategy for more reliable processing of this complex kinetic binding data and compare it with the standard global fitting procedure. In our strategy, we first calculate a dissociation graph to reveal if there are any heterogeneous interactions. Thereafter, a new numerical algorithm, AIDA, is used to get the number of different complex formation reactions for each analyte concentration level. This information is then used to estimate the corresponding complex formation rate constants by fitting to the measured sensorgram one by one. Finally, all estimated rate constants are plotted and clustered, where each cluster represents a complex formation. Synthetic and experimental data obtained from three different QCM biosensor experimental systems having fast (close to steady-state), moderate, and slow kinetics (far from steady-state) were evaluated using the four-step strategy and standard global fitting. The new strategy allowed us to more reliably estimate the number of different complex formations, especially for cases of complex and slow dissociation kinetics. Moreover, the new strategy proved to be more robust as it enables one to handle system drift, i.e., data from biosensor chips that deteriorate over time.